Low-dose semaglutide for weight loss in obese adults
Part of Hormones & metabolism clinical trials.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your BMI (body mass index) is 27.5 or higher based on Asian health standards
- You do not have type 2 diabetes, confirmed by recent blood tests (fasting glucose below 126 mg/dL and HbA1c below 6.5%)
- You can commit to weekly injections and lifestyle counseling sessions
- You have not been on other weight-loss medications recently
- You can provide written informed consent and follow study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
This study tests an injectable medication called semaglutide to help with weight loss in people with a BMI of 28 or higher who have struggled to lose weight before. It compares the study drug to a similar approved weight loss medicine (Wegovy).
This study tests if the medication semaglutide helps adults with overweight or obesity lose weight safely. It includes people with or without type 2 diabetes, and aims to see how well the drug works in a Bangladeshi population.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.